Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer☆
To access this article, please choose from the options below
☆ This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Megumi Medical Foundation of Kanazawa University (Kanazawa, Japan).
PII: S0046-8177(10)00184-X
doi:10.1016/j.humpath.2010.05.006
© 2010 Elsevier Inc. All rights reserved.
